Enhancement of GABAergic transmission by zolpidem, an imidazopyridine with preferential affinity for type I benzodiazepine receptors

https://doi.org/10.1016/0014-2999(89)90840-6Get rights and content

Abstract

The effect of zolpidem, an imidazopyridine derivative with high affinity at the type I benzodiazepine recognition site, on the function of the GABAA/ionophore receptor complex was studied in vitro. Zolpidem, mimicking the action of diazepam, increased [3H]GABA binding, enhanced muscimol-stimulated 36Cl uptake and reduced [35S]TBPS binding in rat cortical membrane preparations. Zolpidem was less effective than diazepam on the above parameters. Zolpidem induced a lower increase of [3H]GABA binding (23 vs. 35%) and muscimol-stimulated 36Cl uptake (22 vs. 40%) and a smaller decrease of [35H]TBPS binding (47 vs. 77%) than diazepam. Yhe finding that zolpidem enhanced the function of GABAergic synapses with an efficacy qualitatively and quantitatively different from that of diazepam suggests that this compound is a partial agonist at the benzodiazepine recognition site. Thus, our results are consistent with the view that the biochemical and pharmacological profile of a benzodiazepine recognition site ligand reflects its efficacy to enhance GABAergic transmission. Whether the preferential affinity of zolpidem at the type I site is involved in its atypical biochemical and pharmacological profile remains to be clarified.

References (36)

  • W. Sieghart et al.

    Comparison of benzodiazepine receptor binding in membranes from human or rat brain

    Neuropharmacology

    (1985)
  • S. Arbilla et al.

    Pharmacological profile of zolpidem at benzodiazepine receptors and electrocorticogram in rats

    Naunyn-Schmiedeb. Arch. Pharmacol.

    (1985)
  • G. Biggio et al.

    Benzodiazepine recognition site ligands: biochemistry and pharmacology

  • C.Y. Chan et al.

    Modulation of neurotransmitter action: control of the γ-aminobutyric acid response through the benzodiazepine receptor

    J. Neurosci.

    (1985)
  • A. Concas et al.

    Changes of 36Cl flux and [35S]TBPS binding induced by stress and GABAergic drugs

  • M.G. Corda et al.

    Enhancement of γ-aminobutyric acid binding by the anxiolytic β-carbolines ZK 93423 and ZK 91296

    J. Neurochem.

    (1987)
  • M.G. Corda et al.

    Enhancement of γ-aminobutyric acid binding by quazepam, a benzodiazepine derivative with preferential affinity for type I benzodiazepine receptors

    J. Neurochem.

    (1986)
  • H. Depoortere et al.

    Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects

    J. Pharmacol. Exp. Ther.

    (1986)
  • Cited by (44)

    • Prenatal exposure to diazepam and alprazolam, but not to zolpidem, affects behavioural stress reactivity in handling-naïve and handling-habituated adult male rat progeny

      2002, Brain Research
      Citation Excerpt :

      Alprazolam (ALP) is a triazolobenzodiazepine with high affinity for specific GABA/BDZ R subtypes [4,27]; it produces anxiolytic, antipanic, antidepressant and weak sedative effects [16,20,50,58,59]. ZOLP is an imidazopyridine, unrelated to benzodiazepines, which shows a high selectivity and affinity for the BDZ R subtype ω1 [2,3,8,28,41], strong sedative, and weak anxiolytic effects [19,42,51,52,66]. In rats, prenatal exposure to benzodiazepines during the ontogenic development of the brain results in a decrease in maturation and in a down-regulation of GABA/BDZ Rs [10,26,38,43,46].

    • Stress and Neuroactive steroids

      2001, International Review of Neurobiology
    View all citing articles on Scopus
    View full text